Source Count: 13 | Weighted Score: 30 | Source Confidence: [4/5] | Primary Tier: 2 | Last Updated: March 10, 2026
Keywords: bioelectromagnetics, electromagnetic field, EMF, PEMF, pulsed electromagnetic field, bone healing, transcranial magnetic stimulation, TMS, rTMS, Becker, Nordenstrom, electrotherapy, biofield, energy healing, Reiki, electrosmog, non-ionizing radiation, Schumann resonance, grounding, earthing, magnetic therapy, piezoelectric, Wolff's law
Category Tags: medicine healing, bioelectromagnetics, electromagnetic therapy, alternative medicine
Cross-References: X_2_02 — Electrotherapy History · O_1_03 — Earth's Electromagnetic Fields · G_3_04 — Biophysics Frameworks · K_1_01 — Consciousness Overview

QUICK SUMMARY

Bioelectromagnetic medicine occupies an unusual position in the medical landscape — a field in which rigorously validated clinical applications (PEMF for bone healing, TMS for depression) coexist with a vast fringe of unsupported claims (magnetic bracelets, "biofield" healing, electrosmog fear-mongering), creating persistent confusion between evidence-based practice and pseudoscience. The biological effects of electromagnetic fields span a spectrum from well-established physics to contested claims to outright quackery, and disentangling them requires careful attention to dose, frequency, mechanism, and evidence quality. Established bioelectromagnetic medicine: (1) Pulsed electromagnetic field therapy (PEMF) for bone healing: the FDA approved PEMF devices for non-union fractures in 1979, based on the work of C. Andrew L. Bassett and colleagues at Columbia University (Bassett et al. 1974, 1977, 1981) — PEMF devices generate low-frequency, low-intensity electromagnetic pulses that stimulate osteoblast activity and bone formation; the mechanism involves activation of voltage-gated calcium channels, upregulation of bone morphogenetic proteins (BMP-2, BMP-7), and stimulation of Wnt/β-catenin signaling; FDA-approved indications include non-union fractures and as an adjunct to lumbar and cervical spinal fusion; meta-analyses confirm efficacy for non-union fractures (Mollon et al. 2008 — OR 4.05 for fracture healing). (2) Transcranial magnetic stimulation (TMS): Anthony Barker (University of Sheffield) demonstrated the first modern TMS device in 1985 — a brief, powerful magnetic pulse (~1.5–2 Tesla) applied to the scalp induces electrical currents in underlying cortical tissue via electromagnetic induction; repetitive TMS (rTMS) was FDA-cleared for treatment-resistant major depression in 2008 (NeuroStar device) — the left dorsolateral prefrontal cortex (DLPFC) is stimulated at high frequency (~10 Hz); multiple randomized sham-controlled trials have demonstrated antidepressant efficacy (Brunoni et al. 2017 — network meta-analysis, World Psychiatry); TMS is also under investigation for OCD (FDA-cleared 2018), PTSD, chronic pain, tinnitus, and stroke rehabilitation. (3) Electroconvulsive therapy (ECT): while technically electrotherapy rather than electromagnetic therapy, ECT (electrically induced seizures under general anesthesia) remains the most effective treatment for severe, treatment-resistant depression (~50–70% remission rates — UK ECT Review Group 2003), though the mechanism remains incompletely understood. The biological basis of bioelectromagnetic effects: all living cells maintain electrical potentials (the resting membrane potential ~-70 mV in neurons; the transmembrane potential is essential for nerve conduction, muscle contraction, and cellular signaling); endogenous bioelectric fields play roles in wound healing (the "current of injury" — Zhao et al. 2006), embryonic development (voltage gradients guide cell migration and tissue patterning — Levin 2014), and cardiac function (electrocardiography, defibrillation); Becker (1985, The Body Electric) documented that salamander limb regeneration involves bioelectric signals and proposed that endogenous electromagnetic fields play underrecognized roles in healing — some of his observations (wound currents, bone piezoelectricity) are confirmed, but his more speculative claims about DC electrical control systems remain unverified. Controversial and unverified claims: (a) Non-ionizing radiation health effects ("electrosmog"): the concern that radiofrequency electromagnetic fields from cell phones, Wi-Fi routers, power lines, and 5G towers cause cancer, infertility, or neurological damage — the International Agency for Research on Cancer (IARC) classified RF-EMF as "possibly carcinogenic to humans" (Group 2B) in 2011, based primarily on the Interphone study (2010) and Hardell group studies showing possible associations between heavy cell phone use and glioma; however, subsequent large-scale studies — the Danish Cohort Study (420,000+ subscribers, no increased cancer risk — Schüz et al. 2006), the Million Women Study (no association — Benson et al. 2013), and the COSMOS study (ongoing prospective cohort) — have not confirmed an association; 5G conspiracy theories are unsupported by physics or epidemiology. (b) Magnetic therapy bracelets/devices: static magnetic field devices marketed for pain relief, improved circulation, and "energy" — systematic reviews (Pittler et al. 2007, CMAJ) find no convincing evidence that static magnets in the strengths used in consumer products (~50–500 gauss) produce therapeutic effects beyond placebo; the magnetic fields are too weak to affect tissue biology or blood flow. (c) "Biofield" therapies (Reiki, therapeutic touch, qi gong healing): claims that practitioners can detect and manipulate an electromagnetic "biofield" or "energy field" surrounding the body — no instrument has detected such a field; the purported mechanism has no basis in known physics; clinical trials are methodologically weak and show effects consistent with placebo and practitioner attention (Rosa et al. 1998, JAMA — a 9-year-old's science fair project famously demonstrated that therapeutic touch practitioners could not detect the human "energy field" at better-than-chance rates). (d) "Earthing/grounding": claims that direct physical contact with the earth's surface transfers beneficial electrons that reduce inflammation, improve sleep, and thin blood — promoted primarily by Ober, Sinatra & Zucker (2010); published studies are small, poorly controlled, and not replicated by independent groups; no plausible biophysical mechanism has been established for the claimed effects.

1. VERIFIED CLAIMS (Tier 1 — FDA-Approved / Replicated / Established)

1.1 PEMF for Bone Healing

• Bassett et al. (1981, Journal of Bone and Joint Surgery): PEMF accelerated healing of non-union fractures with ~80% success rate in originally ununited fractures; FDA approval followed in 1979; mechanism involves calcium channel activation, BMP upregulation, and osteoblast stimulation; efficacy for non-union fractures is confirmed by meta-analysis (Mollon et al. 2008)

1.2 Transcranial Magnetic Stimulation

• FDA clearance (2008) for rTMS in treatment-resistant major depression; Brunoni et al. (2017, World Psychiatry): network meta-analysis of 81 RCTs (~4,233 patients) — high-frequency left DLPFC rTMS significantly superior to sham for remission; TMS is now first-line for treatment-resistant depression in multiple clinical guidelines (APA, NICE)

2. CREDIBLE CLAIMS (Tier 2 — Active Research / Supported but Debated)

2.1 Endogenous Bioelectric Fields in Development and Healing

• Levin (2014): endogenous voltage gradients (transmembrane potential patterns) guide embryonic development, regeneration, and cancer suppression in model organisms (planaria, frog, zebrafish) — bioelectric signals encode spatial information ("bioelectric code") that instructs cell behavior; this is an active area of regenerative medicine with solid animal model data but limited clinical application
• Zhao et al. (2006): wound-generated electrical fields direct cell migration (electrotaxis) in healing epithelium — a physiological role for endogenous electricity in wound healing that is well-supported experimentally

2.2 RF-EMF and Cancer Risk

• The IARC Group 2B classification ("possibly carcinogenic") reflects limited and inconsistent evidence — the Interphone study (2010) showed a possible elevated risk in the heaviest 10% of cell phone users, but potential recall bias; the NTP rodent study (2018) found some evidence of heart schwannomas in male rats at exposures far exceeding normal human exposure; the weight of epidemiological evidence from large prospective cohorts does not support a causal association at typical consumer exposure levels

3. SPECULATIVE CLAIMS (Tier 3 — Possible but Unverified)

3.1 Becker's Bioelectric Control System

• Becker (1985, The Body Electric): proposed an analog DC electrical control system in the body (carried by the perineural system, not neurons) that regulates healing, regeneration, and consciousness; some observations (wound currents, bone piezoelectricity, salamander regeneration signals) are confirmed; the broader control-system theory remains unverified and outside mainstream biomedical models

4. DUBIOUS CLAIMS (Tier 4 — No Credible Source / Contradicted by Evidence)

4.1 Magnetic Bracelets and Static Magnet Therapy

• [UNSUPPORTED] Systematic reviews (Pittler et al. 2007) find no evidence that static magnets in consumer products produce therapeutic effects — the magnetic fields are too weak to influence blood flow, nerve conduction, or tissue healing; marketing claims have no scientific basis

4.2 Biofield/Energy Healing

• [UNSUPPORTED] No detectable "biofield" exists beyond known electromagnetic, thermal, and acoustic emissions of the body — the therapeutic touch/Reiki model of a manipulable energy field has no basis in physics; Rosa et al. (1998, JAMA) famously showed that practitioners could not detect the "human energy field" under blinded conditions

Counter-Arguments & Criticisms

Bioelectromagnetic medicine remains controversial in clinical practice. While FDA-approved applications exist—transcranial magnetic stimulation for depression and pulsed electromagnetic field therapy for bone healing—many broader therapeutic claims lack robust evidence. Ernst (2006) conducted systematic reviews concluding that most electromagnetic therapy claims for pain, wound healing, and chronic conditions are based on low-quality studies with high risk of bias. Skeptics note that the field attracts commercial devices marketed with unsubstantiated health claims (Barrett, 2007). The National Center for Complementary and Integrative Health classifies most electromagnetic therapies as insufficiently studied to recommend. Proposed mechanisms for low-intensity electromagnetic bioeffects remain poorly understood, and existing theoretical models are incomplete.

IMAGES

No images assigned yet.

BIBLIOGRAPHY

1. Bassett, C.A.L., Pilla, A.A.; Pawluk, R.J | 1977 | "A Non-Operative Salvage of Surgically-Resistant Pseudarthroses and Non-Unions by Pulsing Electromagnetic Fields" | Clinical Orthopaedics and Related Research | ∅ | 124::128–143 | ∅ | ∅ | ∅ | ∅ | ∅ | ∅
2. Barker, A.T., Jalinous, R.; Freeston, I.L. | 1985 | "Non-Invasive Magnetic Stimulation of Human Motor Cortex" | Lancet | ∅ | 325.8437::1106–1107 | ∅ | ∅ | doi:10.1016/S0140-6736(85)92413-4 | ∅ | ∅ | ∅
3. Brunoni, A.R. et al | 2017 | "Repetitive Transcranial Magnetic Stimulation for the Acute Treatment of Major Depressive Episodes: A Systematic Review with Network Meta-Analysis" | JAMA Psychiatry | ∅ | 74.2::143–152 | ∅ | ∅ | doi:10.1001/jamapsychiatry.2016.3644 | ∅ | ∅ | ∅
4. Mollon, B. et al | 2008 | "Electrical Stimulation for Long-Bone Fracture-Healing: A Meta-Analysis of Randomized Controlled Trials" | Journal of Bone and Joint Surgery (American) | ∅ | 90.11::2322–2330 | ∅ | ∅ | doi:10.2106/JBJS.H.00111 | ∅ | ∅ | ∅
5. Becker, R.O.; Selden, G | 1985 | ∅ | The Body Electric: Electromagnetism and the Foundation of Life | ∅ | ∅ | New York: William Morrow | ∅ | ∅ | ∅ | ∅ | ∅
6. Levin, M | 2014 | "Molecular Bioelectricity: How Endogenous Voltage Potentials Control Cell Behavior and Instruct Pattern Regulation In Vivo" | Molecular Biology of the Cell | ∅ | 25.24::3835–3850 | ∅ | ∅ | doi:10.1091/mbc.e13-12-0708 | ∅ | ∅ | ∅
7. Zhao, M. et al | 2006 | "Electrical Signals Control Wound Healing Through Phosphatidylinositol-3-OH Kinase-γ and PTEN" | Nature | ∅ | 442.7101::457–460 | ∅ | ∅ | doi:10.1038/nature04925 | ∅ | ∅ | ∅
8. INTERPHONE Study Group | 2010 | "Brain Tumour Risk in Relation to Mobile Telephone Use: Results of the INTERPHONE International Case-Control Study" | International Journal of Epidemiology | ∅ | 39.3::675–694 | ∅ | ∅ | doi:10.1093/ije/dyq079 | ∅ | ∅ | ∅
9. Pittler, M.H., Brown, E.M.; Ernst, E | 2007 | "Static Magnets for Reducing Pain: Systematic Review and Meta-Analysis of Randomized Trials" | Canadian Medical Association Journal | ∅ | 177.7::736–742 | ∅ | ∅ | doi:10.1503/cmaj.061344 | ∅ | ∅ | ∅
10. Rosa, L. et al | 1998 | "A Close Look at Therapeutic Touch" | JAMA | ∅ | 279.13::1005–1010 | ∅ | ∅ | doi:10.1001/jama.279.13.1005 | ∅ | ∅ | ∅
11. Nordenstrom, B.E.W | 1983 | ∅ | Biologically Closed Electric Circuits: Clinical, Experimental, and Theoretical Evidence for an Additional Circulatory System | ∅ | ∅ | Stockholm: Nordic Medical Publications | ∅ | ∅ | ∅ | ∅ | ∅
12. National Toxicology Program | 2018 | "Toxicology and Carcinogenesis Studies in Hsd:Sprague Dawley SD Rats Exposed to Whole-Body Radio Frequency Radiation at a Frequency (900 MHz)" | ∅ | ∅ | ∅ | NTP TR 595 | ∅ | ∅ | ∅ | ∅ | Research Triangle Park, NC: NTP
13. Schüz, J. et al | 2006 | "Cellular Telephone Use and Cancer Risk: Update of a Nationwide Danish Cohort" | Journal of the National Cancer Institute | ∅ | 98.23::1707–1713 | ∅ | ∅ | doi:10.1093/jnci/djj464 | ∅ | ∅ | ∅

CROSS-REFERENCE INDEX

No cross-references yet.

Corrections

• 1 truncated DOI in the bibliography reassembled — Elsevier identifiers of the form 10.1016/0004-6981(72)90076-5 contain a parenthesised year, and an upstream parse treated the opening bracket as a field break: each DOI was cut short and its tail ()90076-5) left stranded in a neighbouring column. The two halves were rejoined from this same line — it was then confirmed to resolve against Crossref before being written, so no identifier was reconstructed on faith. Repaired: 10.1016/S0140-6736(85)92413-4. Corpus hygiene campaign, Phase 4, 2026-07-29.